Alvotech (ALVO)
NASDAQ: ALVO · IEX Real-Time Price · USD
12.24
-0.12 (-0.97%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Alvotech Employees
Alvotech had 1,026 employees as of December 31, 2023. The number of employees increased by 79 or 8.34% compared to the previous year.
Employees
1,026
Change (1Y)
79
Growth (1Y)
8.34%
Revenue / Employee
$111,494
Profits / Employee
-$481,754
Market Cap
3.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,026 | 79 | 8.34% |
Dec 31, 2022 | 947 | 142 | 17.64% |
Mar 4, 2022 | 805 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Sotera Health Company | 3,000 |
Neogen | 2,640 |
iRhythm Technologies | 2,000 |
Guardant Health | 1,779 |
Axonics | 797 |
PROCEPT BioRobotics | 626 |
Prestige Consumer Healthcare | 560 |
Arrowhead Pharmaceuticals | 525 |
ALVO News
- 1 day ago - Alvotech Issues New Shares to Holders of Convertible Bonds - GlobeNewsWire
- 2 days ago - Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024 - GlobeNewsWire
- 7 days ago - Alvotech Receives Conversion Notices for Majority of Convertible Bonds - GlobeNewsWire
- 15 days ago - Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe - GlobeNewsWire
- 22 days ago - Alvotech and STADA add to Strategic Alliance through Denosumab Partnership - GlobeNewsWire
- 22 days ago - Alvotech and STADA add to strategic alliance through denosumab partnership - GlobeNewsWire
- 26 days ago - Alvotech Announces Strategic Refinancing Agreement - GlobeNewsWire
- 4 weeks ago - Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024 - GlobeNewsWire